Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Perri

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Medical and Pediatric Oncology|January 1, 1985
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphomaR T Perri, J I Allen, M M Oken, et al.
Blood|August 1, 1982
Fibronectin enhances in vitro monocyte-macrophage-mediated tumoricidal activityR T Perri, N E Kay, J McCarthy, et al.
American Journal of Hematology|May 1, 1987
In vitro correlates of low dose ara-C efficacy: clinical, cytogenetic, and bone marrow culture analysisD J Weisdorf, R T Perri, D C Arthur, et al.
Cancer Research|July 1, 1992
Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomasG A Niehans, W Jaszcz, V Brunetto, et al.
Leukemia & Lymphoma|March 26, 2002
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150S M Lichtman, G Petroni, R L Schilsky, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Medical and Pediatric Oncology|January 1, 1985
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphomaR T Perri, J I Allen, M M Oken, et al.
Blood|August 1, 1982
Fibronectin enhances in vitro monocyte-macrophage-mediated tumoricidal activityR T Perri, N E Kay, J McCarthy, et al.
American Journal of Hematology|May 1, 1987
In vitro correlates of low dose ara-C efficacy: clinical, cytogenetic, and bone marrow culture analysisD J Weisdorf, R T Perri, D C Arthur, et al.
Cancer Research|July 1, 1992
Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomasG A Niehans, W Jaszcz, V Brunetto, et al.
Leukemia & Lymphoma|March 26, 2002
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150S M Lichtman, G Petroni, R L Schilsky, et al.
Pageof 3